Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Identification and characterization of stromal-like cells with CD207+/low CD1a+/low phenotype derived from histiocytic lesions – a perspective in vitro model for drug testing

Fig. 6

The results of tests aimed at evaluation of sl-pHCs proliferative activity. Representative histograms show the distribution of sl-pHCs in the cell cycle (a-c). Obtained data were used for comparative analysis (d). The proliferation of sl-pHCs was also assessed in the BrdU assay (e). Statistical differences were indicated: * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001, and ****p-value < 0.0001, while the “ns” symbol refers to non-significant differences

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us